BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 6851057)

  • 41. The efficacy of amiodarone for ventricular arrhythmias cannot be predicted with clinical electrophysiological studies.
    Waxman HL
    Int J Cardiol; 1983 Apr; 3(1):76-80. PubMed ID: 6852994
    [No Abstract]   [Full Text] [Related]  

  • 42. Cardiac arrest and sudden death in patients treated with amiodarone for sustained ventricular tachycardia or ventricular fibrillation: risk stratification based on clinical variables.
    DiCarlo LA; Morady F; Sauve MJ; Malone P; Davis JC; Evans-Bell T; Winston SA; Scheinman MM
    Am J Cardiol; 1985 Feb; 55(4):372-4. PubMed ID: 3969871
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of amiodarone in resistant arrhythmias.
    Hollman A; Holt PM
    J R Soc Med; 1980 Dec; 73(12):842-4. PubMed ID: 7452643
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical experience with amiodarone for treatment of recurrent ventricular tachycardia and ventricular fibrillation.
    Heger JJ; Prystowsky EN; Miles WM; Zipes DP
    Br J Clin Pract Suppl; 1986 Apr; 44():16-27. PubMed ID: 3089256
    [No Abstract]   [Full Text] [Related]  

  • 45. [Longterm effects of amiodarone in supraventricular tachyarrhythmias (author's transl)].
    Chadid P; Corbalán R; Fernández M; Luco C; Casanegra P
    Rev Med Chil; 1981 Apr; 109(4):318-23. PubMed ID: 7323518
    [No Abstract]   [Full Text] [Related]  

  • 46. Control of refractory life-threatening ventricular tachyarrhythmias by amiodarone.
    Nademanee K; Hendrickson JA; Cannom DS; Goldreyer BN; Singh BN
    Am Heart J; 1981 Jun; 101(6):759-68. PubMed ID: 7234654
    [No Abstract]   [Full Text] [Related]  

  • 47. [Amiodarone in the control of supraventricular tachyarrhythmias].
    Molina L; Heredia P; Pinto R; Mesa A; Villarreal A; Gutiérrez Fuster E
    Arch Inst Cardiol Mex; 1983; 53(1):13-6. PubMed ID: 6191726
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.
    Rowland E; Krikler DM
    Br Heart J; 1980 Jul; 44(1):82-90. PubMed ID: 7426165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient.
    Leak D
    Am Heart J; 1986 Mar; 111(3):456-62. PubMed ID: 3953353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amiodarone in the treatment of refractory supraventricular and ventricular arrhythmias.
    Wheeler PJ; Puritz R; Ingram DV; Chamberlain DA
    Postgrad Med J; 1979 Jan; 55(639):1-9. PubMed ID: 432163
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical efficacy and electropharmacology of continuous intravenous amiodarone infusion and chronic oral amiodarone in refractory ventricular tachycardia.
    Saksena S; Rothbart ST; Shah Y; Cappello G
    Am J Cardiol; 1984 Aug; 54(3):347-52. PubMed ID: 6465016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amiodarone treatment of critical arrhythmias in children and young adults.
    Garson A; Gillette PC; McVey P; Hesslein PS; Porter CJ; Angell LK; Kaldis LC; Hittner HM
    J Am Coll Cardiol; 1984 Oct; 4(4):749-55. PubMed ID: 6384328
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adverse reactions during treatment with amiodarone hydrochloride.
    McGovern B; Garan H; Kelly E; Ruskin JN
    Br Med J (Clin Res Ed); 1983 Jul; 287(6386):175-80. PubMed ID: 6409240
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amiodarone-induced ventricular fibrillation.
    McComb JM; Logan KR; Khan MM; Geddes JS; Adgey AA
    Eur J Cardiol; 1980; 11(5):381-5. PubMed ID: 7398728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects.
    Zipes DP; Prystowsky EN; Heger JJ
    J Am Coll Cardiol; 1984 Apr; 3(4):1059-71. PubMed ID: 6368644
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of amiodarone in the therapy of primary ventricular arrhythmias in children.
    Pickoff AS; Singh S; Flinn CJ; Wolff GS; Gelband H
    Dev Pharmacol Ther; 1983; 6(2):73-82. PubMed ID: 6861598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amiodarone: pharmacology and antiarrhythmic and adverse effects.
    Naccarelli GV; Rinkenberger RL; Dougherty AH; Giebel RA
    Pharmacotherapy; 1985; 5(6):298-313. PubMed ID: 2934688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of intravenous amiodarone in acute refractory arrhythmias.
    Schmidt A; König W; Binner L; Mayer U; Stauch M
    Clin Cardiol; 1988 Jul; 11(7):481-5. PubMed ID: 3416512
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long term follow-up.
    Peter T; Hamer A; Mandel WJ
    Eur Heart J; 1985 Nov; 6 Suppl D():151-62. PubMed ID: 4085515
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias.
    Primeau R; Agha A; Giorgi C; Shenasa M; Nadeau R
    Can J Cardiol; 1989 Mar; 5(2):98-104. PubMed ID: 2706579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.